yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34718477-22923F49-B0AB-47C2-AF85-83996B00E9AF
Q34718477-22923F49-B0AB-47C2-AF85-83996B00E9AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34718477-22923F49-B0AB-47C2-AF85-83996B00E9AF
Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.
P2860
Q34718477-22923F49-B0AB-47C2-AF85-83996B00E9AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34718477-22923F49-B0AB-47C2-AF85-83996B00E9AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b05ac413013cea001667ad49d1d03cd6abc94346
P2860
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.